Valid

YY/T 0663.2-2016Cardiovascular implants - Endovascular devices - Part 2: Vascular stents (English PDF)

心血管植入物血管内器械第2部分:血管支架

Preview PDF

This is a limited preview

Buy now to download the full PDF (116 pages)

Need quotation for your management?

Get a formal quotation for YY/T 0663.2-2016 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

July 29, 2016

Implementation date

June 1, 2018

Scope

YY/T 0663.2-2016 is the English-translated version of 心血管植入物血管内器械第2部分:血管支架.

YY/T 0663.2-2016 is the Chinese standard "Cardiovascular implants Endovascular devices--Part 2: Vascular stents". Its scope clause reads: 1.1 This Part of YY/T 0663 specifies requirements for vascular stents, based upon current medical knowledge.

With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging and information supplied by the manufacturer.

1.2 The scope of this Part includes vascular stents used to treat vascular lesions or stenoses, or other vascular abnormalities. These devices might or might not incorporate surface modifications of the stent such as drug and/or other coatings.

1.3 Delivery systems are included in this Part if they comprise an integral component of the deployment of the vascular stent. 1.4 Procedures and devices used prior to the introduction of the vascular stent, such as balloon angioplasty devices, are excluded from the scope of this Part.

1.5 Degradation and other time-dependent aspects of bioabsorbable and. Its clauses include terms and definitions; general requirements; intended performance; design attributes; materials; design evaluation; post-market surveillance; manufacturing; sterilization; packaging.

It was issued by the China Food and Drug Administration on JULY 29, 2016 and took effect on JUNE 01, 2017.

Found what you need?

Document preview — YY/T 0663.2-2016

National Standard of the People's Republic of China

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword3
  • Introduction5
  • 1 Scope6
  • 2 Normative references6
  • 3 Terms and definitions7
  • 4 General requirements10
  • 5 Intended performance11
  • 6 Design attributes11
  • 7 Materials13
  • 8 Design evaluation14
  • 9 Post-market surveillance45
  • 10 Manufacturing45
  • 11 Sterilization45
  • 12 Packaging46
  • Annex A (Informative) Attributes of endovascular devices - Vascular stents - Technical and clinical consideration50
  • Annex B (Informative) Bench and analytical tests57
  • Annex C (Informative) Definitions of reportable clinical events61
  • Annex D (Informative) Test methods64
  • Annex E (Informative) Supplement to fatigue durability test analytical approach113
  • Bibliography116

Foreword

YY/T 0663 "Cardiovascular implants Endovascular devices" includes the following three parts.

- Part 1: Endovascular prostheses;

- Part 2: Vascular stents;

- Part 3: Vena cava filters.

This Part is Part 2 of YY/T 0663.

This Part is drafted in accordance with the rules given in GB/T 1.1-2009.

This Part replaces the part related to vascular stents in YY/T 0663-2008 "Non active surgical implants - Particular requirements for cardiac and vascular implants - Specific requirements for arterial stents". Since the date of implementation of this Part, the part related to vascular stents in YY/T 0663-2008 is abolished. Compared with YY/T 0663-2008, the main technical changes in this Part are as follows.

- Modify the scope of application of the standard. The scope of application of this Part includes vascular stents and their delivery systems, excluding endovascular prostheses;

- Modify the structure and content of the design evaluation section;

- ADD Annex A, to give technical and clinical consideration for stents and delivery systems;

- ADD Annex D, to provide a reference test method for preclinical in vitro testing;

- ADD Annex E, to provide supplemental information on fatigue durability test analytical approach.

This Part uses the redraft law to modify and adopt ISO 25539-2:2012 "Cardiovascular implants - Endovascular devices - Part 2: Vascular stents".

Compared with ISO 25539-2:2012, the following changes have been made in this Part.

- This Part puts some of the content from the Scope of ISO 25539-2:2012 into the Introduction;

- For the normative references of ISO 25539-2:2012, this Part replaces the corresponding international standards with national standards and industry standards identical to the corresponding international standards;

- For ISO 25539-2:2012 "Bibliography", this Part replaces the corresponding international and foreign standards with domestic documents;

- Modify "pressure per unit length" in D.5.3.4.6 of ISO 25539-2:2012 to "pressure" and the unit from "kPa/mm" to "kPa".

1 Scope

1.1 This Part of YY/T 0663 specifies requirements for vascular stents, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging and information supplied by the manufacturer.

1.2 The scope of this Part includes vascular stents used to treat vascular lesions or stenoses, or other vascular abnormalities. These devices might or might not incorporate surface modifications of the stent such as drug and/or other coatings.

1.3 Delivery systems are included in this Part if they comprise an integral component of the deployment of the vascular stent.

1.4 Procedures and devices used prior to the introduction of the vascular stent, such as balloon angioplasty devices, are excluded from the scope of this Part.

1.5 Degradation and other time-dependent aspects of bioabsorbable and polymeric stents and coatings are not addressed by this Part.

1.6 With the exception of sterilization, this Part does not address requirements for the evaluation of animal tissue products.

2 Normative references

The following documents are indispensable for the application of this document.

For the dated references, only the editions with the dates indicated are applicable to this document. For the undated references, the latest edition (including all the amendments) are applicable to this document.

GB/T 16886.1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (GB/T 16886.1-2011, ISO 10993-1:2009, IDT)

GB 18278.1 Sterilization of health care products - Moist heat - Part 1:

Requirements for the development, validation and routine control of a sterilization process for medical devices (GB 18278.1-2015, ISO 17665-1:2006, IDT)

GB 18279.1 Sterilization of health care products - Ethylene oxide - Part 1:

Requirements for development, validation and routine control of a sterilization process for medical devices (GB 18279.1-2015, ISO 11135-1:2007, IDT)

GB 18280 Sterilization of health care products - Requirement for validation and routine control - Radiation sterilization (GB 18280-2000, ISO 11137:1995, IDT)

GB/T 19633 Packaging for terminally sterilized medical devices (GB/T 19633-2005, ISO 11607:2003, IDT)

GB/T 19974 Sterilization of health care products - General requirement for characterization of a sterilization agent and the development, validation and routine control of a sterilization process for medical devices (GB/T 19974-2005, ISO 14937:2000, IDT)

YY/T 0297 Clinical investigation of medical devices (YY/T 0297-1997, ISO 14155:1996, IDT)

YY/T 0316-2008 Medical devices - Application of risk management to medical devices (ISO 14971:2007, IDT)

YY/T 0640-2016 Non-active surgical implants - General requirements (ISO 14630:2012, IDT)

YY 0970 Sterilization of single-use medical devices incorporating materials of animal origin - Validation and routine control of sterilization by liquid sterilant (YY 0970-2013, ISO 14160:1998, IDT)

3 Terms and definitions

For the purposes of this document, the terms and definitions in YY/T 0640 and the following apply.

Note: Bench and analytical tests are described in Annex B. Reportable clinical events are defined in Annex C.

3.1 Balloon-assisted deployment

Use of a balloon to facilitate the complete deployment (or expansion) of a self-expanding stent.

3.2 Balloon winging

Cross-sectional shape of the balloon when deflated which can cause problems during withdrawal.

Note: Examples include stent migration, damage to host vessel or balloon, and inability to remove the balloon.

3.3 Delivery system

System or mechanism used to deliver the stent to the targeted position and to deploy the stent. […]

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 116 pages — is available in the English PDF.

Referenced standards

Similar standards

How to Download YY/T 0663.2-2016

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Instant delivery (0–9 sec)

    Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
116 pages
Instant delivery (0–9 sec)
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 0663.2-2016

$780.00